基于放射组学特征的呼吸门控 PET/CT 与非门控 PET/CT 在肺部病变中的变异性和诊断效果比较

IF 4.5 2区 医学 Q1 ONCOLOGY Lung Cancer Pub Date : 2024-07-14 DOI:10.1016/j.lungcan.2024.107889
Shengyun Huang , Caifang Cao , Linna Guo , Chengze Li , Feng Zhang , Yiluo Li , Ying Liang , Wei Mu
{"title":"基于放射组学特征的呼吸门控 PET/CT 与非门控 PET/CT 在肺部病变中的变异性和诊断效果比较","authors":"Shengyun Huang ,&nbsp;Caifang Cao ,&nbsp;Linna Guo ,&nbsp;Chengze Li ,&nbsp;Feng Zhang ,&nbsp;Yiluo Li ,&nbsp;Ying Liang ,&nbsp;Wei Mu","doi":"10.1016/j.lungcan.2024.107889","DOIUrl":null,"url":null,"abstract":"<div><h3>Objectives</h3><p>To investigate the variability and diagnostic efficacy of respiratory-gated (RG) PET/CT based radiomics features compared to ungated (UG) PET/CT in the differentiation of non-small cell lung cancer (NSCLC) and benign lesions.</p></div><div><h3>Methods</h3><p>117 patients with suspected lung lesions from March 2020 to May 2021 and consent to undergo UG PET/CT and chest RG PET/CT (including phase-based quiescent period gating, pQPG and phase-matched 4D PET/CT, 4DRG) were prospectively included. 377 radiomics features were extracted from PET images of each scan. Paired <em>t</em> test was used to compare UG and RG features for inter-scan variability analysis. We developed three radiomics models with UG and RG features (i.e. UGModel, pQPGModel and 4DRGModel). ROC curves were used to compare diagnostic efficiencies, and the model-level comparison of diagnostic value was performed by five-fold cross-validation. A P value &lt; 0.05 was considered as statistically significant.</p></div><div><h3>Results</h3><p>A total of 111 patients (average age ± standard deviation was 59.1 ± 11.6 y, range, 29 – 88 y, and 63 were males) with 209 lung lesions were analyzed for features variability and the subgroup of 126 non-metastasis lesions in 91 patients without treatment before PET/CT were included for diagnosis analysis. 101/377 (26.8 %) 4DRG features and 82/377 (21.8 %) pQPG features showed significant difference compared to UG features (both P&lt;0.05). 61/377 (16.2 %) and 59/377 (15.6 %) of them showed significantly better discriminant ability (ΔAUC% (i.e. (AUC<sub>RG</sub> – AUC<sub>UG</sub>) / AUC<sub>UG</sub>×100 %) &gt; 0 and P&lt;0.05) in malignant recognition, respectively. For the model-level comparison, 4DRGModel achieved the highest diagnostic efficacy (sen 73.2 %, spe 87.3 %) compared with UGModel (sen 57.7 %, spe 76.4 %) and pQPGModel (sen 63.4 %, spe 81.8 %).</p></div><div><h3>Conclusion</h3><p>RG PET/CT performs better in the quantitative assessment of metabolic heterogeneity for lung lesions and the subsequent diagnosis in patients with NSCLC compared with UG PET/CT.</p></div>","PeriodicalId":18129,"journal":{"name":"Lung Cancer","volume":"194 ","pages":"Article 107889"},"PeriodicalIF":4.5000,"publicationDate":"2024-07-14","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Comparison of the variability and diagnostic efficacy of respiratory-gated PET/CT based radiomics features with ungated PET/CT in lung lesions\",\"authors\":\"Shengyun Huang ,&nbsp;Caifang Cao ,&nbsp;Linna Guo ,&nbsp;Chengze Li ,&nbsp;Feng Zhang ,&nbsp;Yiluo Li ,&nbsp;Ying Liang ,&nbsp;Wei Mu\",\"doi\":\"10.1016/j.lungcan.2024.107889\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<div><h3>Objectives</h3><p>To investigate the variability and diagnostic efficacy of respiratory-gated (RG) PET/CT based radiomics features compared to ungated (UG) PET/CT in the differentiation of non-small cell lung cancer (NSCLC) and benign lesions.</p></div><div><h3>Methods</h3><p>117 patients with suspected lung lesions from March 2020 to May 2021 and consent to undergo UG PET/CT and chest RG PET/CT (including phase-based quiescent period gating, pQPG and phase-matched 4D PET/CT, 4DRG) were prospectively included. 377 radiomics features were extracted from PET images of each scan. Paired <em>t</em> test was used to compare UG and RG features for inter-scan variability analysis. We developed three radiomics models with UG and RG features (i.e. UGModel, pQPGModel and 4DRGModel). ROC curves were used to compare diagnostic efficiencies, and the model-level comparison of diagnostic value was performed by five-fold cross-validation. A P value &lt; 0.05 was considered as statistically significant.</p></div><div><h3>Results</h3><p>A total of 111 patients (average age ± standard deviation was 59.1 ± 11.6 y, range, 29 – 88 y, and 63 were males) with 209 lung lesions were analyzed for features variability and the subgroup of 126 non-metastasis lesions in 91 patients without treatment before PET/CT were included for diagnosis analysis. 101/377 (26.8 %) 4DRG features and 82/377 (21.8 %) pQPG features showed significant difference compared to UG features (both P&lt;0.05). 61/377 (16.2 %) and 59/377 (15.6 %) of them showed significantly better discriminant ability (ΔAUC% (i.e. (AUC<sub>RG</sub> – AUC<sub>UG</sub>) / AUC<sub>UG</sub>×100 %) &gt; 0 and P&lt;0.05) in malignant recognition, respectively. For the model-level comparison, 4DRGModel achieved the highest diagnostic efficacy (sen 73.2 %, spe 87.3 %) compared with UGModel (sen 57.7 %, spe 76.4 %) and pQPGModel (sen 63.4 %, spe 81.8 %).</p></div><div><h3>Conclusion</h3><p>RG PET/CT performs better in the quantitative assessment of metabolic heterogeneity for lung lesions and the subsequent diagnosis in patients with NSCLC compared with UG PET/CT.</p></div>\",\"PeriodicalId\":18129,\"journal\":{\"name\":\"Lung Cancer\",\"volume\":\"194 \",\"pages\":\"Article 107889\"},\"PeriodicalIF\":4.5000,\"publicationDate\":\"2024-07-14\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Lung Cancer\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://www.sciencedirect.com/science/article/pii/S0169500224004239\",\"RegionNum\":2,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q1\",\"JCRName\":\"ONCOLOGY\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Lung Cancer","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0169500224004239","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"ONCOLOGY","Score":null,"Total":0}
引用次数: 0

摘要

方法前瞻性地纳入了2020年3月至2021年5月期间疑似肺部病变并同意接受UG PET/CT和胸部RG PET/CT(包括基于相位的静息期门控(pQPG)和相位匹配4D PET/CT(4DRG))检查的117例患者。从每次扫描的 PET 图像中提取了 377 个放射组学特征。使用配对 t 检验比较 UG 和 RG 特征,进行扫描间变异性分析。我们建立了三种具有 UG 和 RG 特征的放射组学模型(即 UG 模型、pQPG 模型和 4DRG 模型)。我们使用 ROC 曲线来比较诊断效率,并通过五倍交叉验证来比较模型的诊断价值。结果 共有 111 名患者(平均年龄(± 标准差)为 59.1 ± 11.6 岁,范围为 29 - 88 岁,男性 63 名)的 209 个肺部病灶进行了特征变异性分析,并将 PET/CT 前未经治疗的 91 名患者中的 126 个非转移病灶亚组纳入诊断分析。101/377(26.8%)例的 4DRG 特征和 82/377 (21.8%)例的 pQPG 特征与 UG 特征相比有显著差异(P<0.05)。其中 61/377 (16.2 %) 和 59/377 (15.6 %) 在恶性识别中分别显示出明显更好的判别能力(ΔAUC%(即 (AUCRG - AUCUG) / AUCUG×100 %)> 0 和 P<0.05)。结论与 UG PET/CT 相比,RG PET/CT 在定量评估 NSCLC 患者肺部病变的代谢异质性及后续诊断方面表现更好。
本文章由计算机程序翻译,如有差异,请以英文原文为准。

摘要图片

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
Comparison of the variability and diagnostic efficacy of respiratory-gated PET/CT based radiomics features with ungated PET/CT in lung lesions

Objectives

To investigate the variability and diagnostic efficacy of respiratory-gated (RG) PET/CT based radiomics features compared to ungated (UG) PET/CT in the differentiation of non-small cell lung cancer (NSCLC) and benign lesions.

Methods

117 patients with suspected lung lesions from March 2020 to May 2021 and consent to undergo UG PET/CT and chest RG PET/CT (including phase-based quiescent period gating, pQPG and phase-matched 4D PET/CT, 4DRG) were prospectively included. 377 radiomics features were extracted from PET images of each scan. Paired t test was used to compare UG and RG features for inter-scan variability analysis. We developed three radiomics models with UG and RG features (i.e. UGModel, pQPGModel and 4DRGModel). ROC curves were used to compare diagnostic efficiencies, and the model-level comparison of diagnostic value was performed by five-fold cross-validation. A P value < 0.05 was considered as statistically significant.

Results

A total of 111 patients (average age ± standard deviation was 59.1 ± 11.6 y, range, 29 – 88 y, and 63 were males) with 209 lung lesions were analyzed for features variability and the subgroup of 126 non-metastasis lesions in 91 patients without treatment before PET/CT were included for diagnosis analysis. 101/377 (26.8 %) 4DRG features and 82/377 (21.8 %) pQPG features showed significant difference compared to UG features (both P<0.05). 61/377 (16.2 %) and 59/377 (15.6 %) of them showed significantly better discriminant ability (ΔAUC% (i.e. (AUCRG – AUCUG) / AUCUG×100 %) > 0 and P<0.05) in malignant recognition, respectively. For the model-level comparison, 4DRGModel achieved the highest diagnostic efficacy (sen 73.2 %, spe 87.3 %) compared with UGModel (sen 57.7 %, spe 76.4 %) and pQPGModel (sen 63.4 %, spe 81.8 %).

Conclusion

RG PET/CT performs better in the quantitative assessment of metabolic heterogeneity for lung lesions and the subsequent diagnosis in patients with NSCLC compared with UG PET/CT.

求助全文
通过发布文献求助,成功后即可免费获取论文全文。 去求助
来源期刊
Lung Cancer
Lung Cancer 医学-呼吸系统
CiteScore
9.40
自引率
3.80%
发文量
407
审稿时长
25 days
期刊介绍: Lung Cancer is an international publication covering the clinical, translational and basic science of malignancies of the lung and chest region.Original research articles, early reports, review articles, editorials and correspondence covering the prevention, epidemiology and etiology, basic biology, pathology, clinical assessment, surgery, chemotherapy, radiotherapy, combined treatment modalities, other treatment modalities and outcomes of lung cancer are welcome.
期刊最新文献
Lorlatinib-associated weight gain and dyslipidaemia: A retrospective analysis and implications for future care. Radiological follow-up in patients with resected pulmonary carcinoids: Should we reduce radiation exposure? Brief Report: Should a prior cancer history be reevaluated as an exclusion for clinical trial participation? Evaluating efficacy and safety of a novel registration-free CT-guided needle biopsy navigation system (RC 120): A multicenter, prospective clinical trial Oral propranolol for the treatment of amivantamab-induced scalp ulcers with granulation tissues
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1